These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35540315)

  • 1. Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion.
    Huang Y; Gui S
    RSC Adv; 2018 Feb; 8(13):6978-6987. PubMed ID: 35540315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
    Rajesh S; Zhai J; Drummond CJ; Tran N
    J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cubic and hexagonal liquid crystals as drug delivery systems.
    Chen Y; Ma P; Gui S
    Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelation of Lyotropic Liquid-Crystal Phases-The Interplay between Liquid Crystalline Order and Physical Gel Formation.
    Dieterich S; Sottmann T; Giesselmann F
    Langmuir; 2019 Dec; 35(51):16793-16802. PubMed ID: 31621334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
    Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
    AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning gelled lyotropic liquid crystals (LLCs) - probing the influence of different low molecular weight gelators on the phase diagram of the system H
    Steck K; van Esch JH; Smith DK; Stubenrauch C
    Soft Matter; 2019 Apr; 15(15):3111-3121. PubMed ID: 30758020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelling Lyotropic Liquid Crystals with the Organogelator 1,3:2,4-Dibenzylidene-d-sorbitol Part I: Phase Studies and Sol-Gel Transitions.
    Steck K; Stubenrauch C
    Langmuir; 2019 Dec; 35(52):17132-17141. PubMed ID: 31356080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning in-meso-crystallized lysozyme polymorphism by lyotropic liquid crystal symmetry.
    Zabara A; Amar-Yuli I; Mezzenga R
    Langmuir; 2011 May; 27(10):6418-25. PubMed ID: 21506575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oil and drug control the release rate from lyotropic liquid crystals.
    Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
    J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
    Zhang H; Wang Z
    Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
    Libster D; Aserin A; Garti N
    J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning Nanostructured Lyotropic Liquid Crystalline Mesophases in Lipid Nanoparticles with Protic Ionic Liquids.
    Zhai J; Sarkar S; Tran N; Pandiancherri S; Greaves TL; Drummond CJ
    J Phys Chem Lett; 2021 Jan; 12(1):399-404. PubMed ID: 33356288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature-Inspired Design and Application of Lipidic Lyotropic Liquid Crystals.
    Mezzenga R; Seddon JM; Drummond CJ; Boyd BJ; Schröder-Turk GE; Sagalowicz L
    Adv Mater; 2019 Aug; 31(35):e1900818. PubMed ID: 31222858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme Kinetics in Liquid Crystalline Mesophases: Size Matters, But Also Topology.
    Sun W; Vallooran JJ; Mezzenga R
    Langmuir; 2015 Apr; 31(15):4558-65. PubMed ID: 25806598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micellar Mimicry of Intermetallic C14 and C15 Laves Phases by Aqueous Lyotropic Self-Assembly.
    Baez-Cotto CM; Mahanthappa MK
    ACS Nano; 2018 Apr; 12(4):3226-3234. PubMed ID: 29611426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear rheology of lyotropic liquid crystals: a case study.
    Mezzenga R; Meyer C; Servais C; Romoscanu AI; Sagalowicz L; Hayward RC
    Langmuir; 2005 Apr; 21(8):3322-33. PubMed ID: 15807570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.